Copyright
©The Author(s) 2016.
World J Hepatol. Nov 8, 2016; 8(31): 1309-1317
Published online Nov 8, 2016. doi: 10.4254/wjh.v8.i31.1309
Published online Nov 8, 2016. doi: 10.4254/wjh.v8.i31.1309
Risk factor of HCC recurrence | After liver resection | After liver transplantation |
Serological | ||
AFP | > 400 ng/mL[49] | > 1000 ng/mL[34,35] |
Tumor gross | ||
Tumor size | > 3 cm[30] or > 5 cm[37,41,65] | > 6 cm[35] |
Tumor number | > 3[65] | ≥ 4[35] |
Satellite nodules | Yes[30,63,66] | Yes[33] |
Tumor microscopic | ||
Tumor differentiation | Intermediate, or poor differentiation, or undifferentiation[30,49,65] | Poor differentiation, or undifferentiation[33] |
Microvascular invasion | Yes[30,37,41,49,64-66] | Yes[33,34] |
Liver parenchyma | ||
Severity of cirrhosis | Controversial[67-69] | No |
Milan criteria | Yes[68] (predict recurrence within/beyond MC) | Yes[3] |
- Citation: Yang PC, Ho CM, Hu RH, Ho MC, Wu YM, Lee PH. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma. World J Hepatol 2016; 8(31): 1309-1317
- URL: https://www.wjgnet.com/1948-5182/full/v8/i31/1309.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i31.1309